Hostility as a predictor of survival in patients with coronary artery disease

Psychosomatic Medicine
Stephen H BoyleJohn C Barefoot

Abstract

This article presents a reanalysis of an earlier study that reported a nonsignificant relation between the 50-item Cook-Medley Hostility Scale (CMHS) and survival in a sample of coronary patients. Since publication of those results, there have been significant developments in the measurement of hostility that suggest that an abbreviated scale may be a better predictor of health outcomes. This study examined the ability of the total CMHS and an abbreviated form of the CMHS (ACM) to predict survival in a sample of patients with documented coronary artery disease (CAD) with increased statistical power. Nine hundred thirty-six patients (83% were male; mean age = 51.48) with CAD who were followed for an average of 14.9 years. The ACM consisted of the combination of the cynicism, hostile attribution, hostile affect, and aggressive responding subscales that were identified in an earlier study (Barefoot et al. [1989]) by a rational analysis of the item content. The relation between hostility and survival was examined with Cox proportional hazard models (hazard ratios [HRs] based on a two standard deviation difference). Controlling for disease severity, the ACM was a significant predictor for both CHD mortality (HR = 1.33, p <.009) and ...Continue Reading

Associated Clinical Trials

References

Sep 1, 1989·The American Journal of Cardiology·J C BarefootR B Williams
Jan 1, 1989·Psychosomatic Medicine·J C BarefootR B Williams
Mar 1, 1983·Psychosomatic Medicine·J C BarefootR B Williams
May 1, 1983·Psychosomatic Medicine·R B ShekelleO Paul
May 21, 1997·JAMA : the Journal of the American Medical Association·E C GulletteD S Krantz
Nov 25, 2000·Journal of the American College of Cardiology·P AngererC von Schacky
May 31, 2001·Psychosomatic Medicine·R P SloanM M Myers
Jun 4, 2002·Journal of Cardiopulmonary Rehabilitation·Beverly H BrummettJohn C Barefoot
Oct 3, 2002·Circulation·Rachel LampertDiwakar Jain
Dec 14, 2002·American Journal of Epidemiology·Lily A ChaputKaren A Matthews
Oct 23, 2003·JAMA : the Journal of the American Medical Association·Redford B WilliamsNeil Schneiderman

❮ Previous
Next ❯

Citations

Oct 3, 2008·Journal of Behavioral Medicine·Tin Kwang LinChin-Lon Lin
Dec 24, 2008·Journal of Clinical Psychology in Medical Settings·Karen B GrothePhillip J Brantley
Feb 12, 2008·International Journal of Epidemiology·Hermann NabiArchana Singh-Manoux
Apr 18, 2007·Cardiology in Review·Julie K Schulman, Shannon Stromberg
Jan 27, 2010·Psychosomatic Medicine·Michael V StantonSherman A James
Dec 1, 2007·Perspectives on Psychological Science : a Journal of the Association for Psychological Science·Brent W RobertsLewis R Goldberg
Aug 25, 2007·Annual Review of Clinical Psychology·Timothy W Smith, Justin MacKenzie
May 27, 2010·Srpski arhiv za celokupno lekarstvo·Gordana NikolićMara Vucurević
Dec 1, 2006·Age·Peter MartinUNKNOWN Georgia Centenarian Study
Dec 24, 2008·Journal of Clinical Psychology in Medical Settings·Zuzana SkodovaS A Reijneveld
Jul 19, 2011·Journal of Aging Research·Benjamin P ChapmanPaul Duberstein
Aug 31, 2011·International Journal of Hypertension·Monique S RoyAlec Roy
Apr 26, 2007·Journal of Health Organization and Management·Dusan SelkoBranislav Liska
Aug 12, 2014·Archives of Gerontology and Geriatrics·Jenaleen LawFrances Kay-Lambkin
Sep 22, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Patrick SmithVäinö Turjanmaa
Jan 28, 2012·Journal of Psychosomatic Research·Richard D HayesRobert Stewart
Aug 4, 2009·Brain, Behavior, and Immunity·Denise Janicki-DevertsWilliam J Doyle
Nov 6, 2007·Journal of Psychosomatic Research·Bernhard LacheChristoph Herrmann-Lingen
Jun 28, 2005·The American Journal of Cardiology·Stephen H BoyleJohn C Barefoot
Dec 27, 2005·Brain, Behavior, and Immunity·Jennifer E GrahamRonald Glaser
Sep 22, 2012·Social Science & Medicine·Katherine King
Mar 14, 2009·Journal of the American College of Cardiology·Yoichi Chida, Andrew Steptoe
Jan 18, 2011·Physiology & Behavior·Gretha J BoersmaAnton J W Scheurink
Oct 6, 2016·International Journal of Behavioral Medicine·Biing-Jiun Shen, Jen-Tzer Gau
Apr 4, 2017·The American Journal of Medicine·Maryam SattariRebecca J Beyth
Mar 14, 2018·Psychology & Health·Cristina Guerrero RodríguezConsuelo Gómez-Íñiguez
Mar 15, 2006·Current Opinion in Anaesthesiology·Thomas Uhlig, Konrad W Kallus
Nov 13, 2007·Addiction·Stephen H BoyleJohn C Barefoot
Apr 12, 2007·Psychotherapy and Psychosomatics·Margarita BeresnevaitéR Michael Bagby
Nov 11, 2009·Holistic Nursing Practice·Julia Wilkins, Amy Janel Eisenbraun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.